BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Ryan Richardson joined BioNTech in 2018 and has served as Chief Strategy Officer since January 2020. During his time at the Company, he contributed significantly to BioNTech’s successful development, ...

New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

BioNTech will pay OncoC4 $200 million up front and get global rights to its drug. Privately held OncoC4 could earn milestone payments, plus royalties if the research leads to a commercialized product.

BioNTech’s partner Pfizer ranked 8th last year with $41.9 billion in 2020 revenue. Meanwhile, Pfizer recently raised its 2021 COVID-19 vaccine revenue guidance to $33.5 billion, so it should ...

BioNTech has 10 products which are in phase 2 and phase 3 trials. When asked about R&D funding, Holstein said that the company feels “comfortable” with the $2.4 billion to $2.6 billion it is ...

BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...